{"id":"https://openalex.org/W2593351814","doi":"https://doi.org/10.1182/blood.v112.11.1071.1071","title":"Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Normal and CML CD34+ Progenitor Cells Impairs Myeloid Differentiation.","display_name":"Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Normal and CML CD34+ Progenitor Cells Impairs Myeloid Differentiation.","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2593351814","doi":"https://doi.org/10.1182/blood.v112.11.1071.1071","mag":"2593351814"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.1071.1071","doi":"https://doi.org/10.1182/blood.v112.11.1071.1071","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.1071.1071","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009149109","display_name":"Vivian G. Oehler","orcid":"https://orcid.org/0000-0002-1630-4151","observed_orcids":["https://orcid.org/0000-0002-1630-4151"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivian Oehler","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112431905","display_name":"Carrie C. Cummings","orcid":"https://orcid.org/0009-0003-8441-6299","observed_orcids":["https://orcid.org/0009-0003-8441-6299"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie Cummings","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056971000","display_name":"Kathleen M. Sabo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Sabo","raw_affiliation_strings":["Division of Hematology, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013754928","display_name":"Brent Lee Wood","orcid":"https://orcid.org/0000-0001-7414-3969","observed_orcids":["https://orcid.org/0000-0001-7414-3969"]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brent Wood","raw_affiliation_strings":["Seattle Cancer Care Alliance, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Cancer Care Alliance, Seattle, WA, USA","institution_ids":["https://openalex.org/I1332479046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048654505","display_name":"Katherine Adams Guthrie","orcid":"https://orcid.org/0000-0001-7257-8280","observed_orcids":["https://orcid.org/0000-0001-7257-8280"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Guthrie","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023949296","display_name":"Ted Alan Gooley","orcid":"https://orcid.org/0000-0002-8182-3652","observed_orcids":["https://orcid.org/0000-0002-8182-3652"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ted Gooley","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088294011","display_name":"Era L. Pogosova\u2010Agadjanyan","orcid":"https://orcid.org/0000-0002-9060-358X","observed_orcids":["https://orcid.org/0000-0002-9060-358X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Era Pogosova-Agadjanyan","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019784365","display_name":"Paula Ladne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula Ladne","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058845981","display_name":"Derek L. Stirewalt","orcid":"https://orcid.org/0000-0003-4151-3171","observed_orcids":["https://orcid.org/0000-0003-4151-3171"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Derek Stirewalt","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055816987","display_name":"Janis L. Abkowitz","orcid":"https://orcid.org/0000-0002-1820-5341","observed_orcids":["https://orcid.org/0000-0002-1820-5341"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janis L. Abkowitz","raw_affiliation_strings":["Division of Hematology, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089541690","display_name":"Jerald P. Radich","orcid":"https://orcid.org/0000-0002-1618-230X","observed_orcids":["https://orcid.org/0000-0002-1618-230X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerald Radich","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2156,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.6483969,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"1071","last_page":"1071"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prame","display_name":"PRAME","score":0.9929999709129333},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/myeloid-differentiation","display_name":"myeloid differentiation","score":0.8429999947547913},{"id":"https://openalex.org/keywords/cd34-hematopoietic-progenitor-cells","display_name":"CD34+ hematopoietic progenitor cells","score":0.9079999923706055},{"id":"https://openalex.org/keywords/retinoic-acid-signaling","display_name":"retinoic acid signaling","score":0.7900000214576721},{"id":"https://openalex.org/keywords/blast-crisis","display_name":"blast crisis","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cfu-gm","display_name":"CFU-GM","score":0.6159999966621399},{"id":"https://openalex.org/keywords/cfu-g","display_name":"CFU-G","score":0.6100000143051147},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.5799999833106995},{"id":"https://openalex.org/keywords/gene-silencing","display_name":"gene silencing","score":0.6299999952316284},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5690000057220459},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.6570000052452087},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.3109999895095825},{"id":"https://openalex.org/keywords/hematopoiesis","display_name":"hematopoiesis","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6264585256576538},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5521390438079834},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.5262597799301147},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5129282474517822},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5045157670974731},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4859146177768707},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4748513996601105},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.4629085958003998},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.46243250370025635},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.37208646535873413},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3284072279930115},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.19546175003051758},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.1071.1071","doi":"https://doi.org/10.1182/blood.v112.11.1071.1071","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.1071.1071","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2151883962","https://openalex.org/W2574385171","https://openalex.org/W2162261881","https://openalex.org/W2077167899","https://openalex.org/W2286502341","https://openalex.org/W2012810764","https://openalex.org/W2091537353","https://openalex.org/W2164971085","https://openalex.org/W2418465661","https://openalex.org/W2159966658"],"abstract_inverted_index":{"Abstract":[0],"PRAME,":[1],"or":[2,69,193,198],"the":[3,36,48,105,212,229,356,393,402,417,444,463,470,577],"Preferentially":[4],"Expressed":[5],"Antigen":[6],"in":[7,14,35,43,52,71,79,130,144,155,211,222,228,238,246,259,267,275,278,283,297,315,324,336,355,368,401,406,416,433,443,462,533,547,556,569,589,604,611,635,652],"Melanoma,":[8],"is":[9,67,76,440,450,456,544,559,596],"an":[10,517],"attractive":[11],"therapeutic":[12],"target":[13],"cancer":[15],"treatment.":[16],"It":[17,601],"has":[18,388],"been":[19,389],"described":[20,390],"as":[21,28,391,487,624,645],"a":[22,29,80,162,179,205,264,605,633],"tumor-associated":[23],"antigen":[24],"and":[25,58,90,136,168,257,293,308,344,351,358,425,435,551,580],"more":[26,165],"recently":[27],"co-repressor":[30],"of":[31,38,50,82,104,146,164,273,303,360,396,404,419,452,502,520],"retinoic":[32,40,606],"acid":[33,41,607],"signaling":[34,400],"presence":[37,357,403,418],"all-trans":[39],"(ATRA)":[42],"tumor":[44,408],"cell":[45,423,437,446,465,472,513],"lines.":[46,410,438],"However,":[47],"function":[49,237,429],"PRAME":[51,64,101,127,153,209,217,236,242,274,287,316,325,333,345,369,381,397,411,428,439,455,483,509,531,543,567,586,593,622],"hematopoietic":[53,73,240],"cells":[54,241,253,262,277,288,327,347,375,409,504,535,612],"remains":[55],"unclear.":[56],"We":[57,149],"others":[59],"have":[60],"reported":[61],"that":[62,152,377,620,640],"while":[63],"mRNA":[65],"expression":[66,154,210,218,227,272,296,366,495,553,568,623],"absent":[68],"low":[70,142],"CD34+":[72,248,261,339,571],"progenitors,":[74],"it":[75],"heterogeneously":[77],"over-expressed":[78],"number":[81,519],"hematologic":[83],"malignancies":[84],"including":[85],"acute":[86],"myeloid":[87,92,268,285,414,574,614,630,637],"leukemia":[88,93],"(AML)":[89],"chronic":[91,116],"(CML).":[94],"In":[95,123,232,499,541],"our":[96],"previously":[97],"published":[98],"microarray":[99],"studies,":[100],"was":[102,128,137,204,219,243,311,321,334,342,430,505,527,583,587],"one":[103],"most":[106],"statistically":[107],"significantly":[108,313],"differentially":[109],"expressed":[110,129,138,245,442,457,545],"genes":[111],"with":[112,178,561,613],"CML":[113,158,265,338,434,445,550,590],"progression":[114],"from":[115,254,263,469,627],"phase":[117,549],"(CP)":[118],"to":[119,174,182,188,234,305,329,481,489,524,565,629,649],"blast":[120,269],"crisis":[121],"(BC).":[122],"independent":[124,280],"validation":[125],"studies":[126],"all":[131],"but":[132,530,639],"on":[133,201,398,413,539,598],"BC":[134,631],"patient":[135,266],"at":[139,458,554,576],"only":[140,610],"very":[141],"levels":[143,461],"50%":[145],"CP":[147,157,557,628],"patients.":[148,231],"then":[150],"hypothesized":[151],"diagnostic":[156],"patients":[159,177,190,625],"may":[160,169,379],"be":[161,475],"marker":[163],"advanced":[166,548],"disease,":[167],"therefore":[170],"predict":[171],"poorer":[172,562],"response":[173,181,564],"therapy.":[175],"Thirty-nine":[176],"good":[180],"imatinib":[183],"mesylate":[184],"(IM)":[185],"were":[186],"compared":[187,488],"17":[189],"who":[191,194],"progressed":[192],"achieved":[195],"suboptimal":[196],"cytogenetic":[197],"molecular":[199],"responses":[200],"IM.":[202,566],"There":[203],"trend":[206],"towards":[207],"increased":[208,290,343,349,518],"poor":[213,223],"responders.":[214],"The":[215,301,383],"median":[216],"86.3":[220],"copies":[221],"responders":[224],"vs.":[225,373],"no":[226,537],"remaining":[230],"order":[233],"examine":[235],"primary":[239,260,337,371],"aberrantly":[244],"normal":[247,276,570],"selected":[249],"mobilized":[250],"peripheral":[251],"blood":[252],"healthy":[255],"donors":[256],"silenced":[258,335,346,588],"crisis.":[270],"Forced":[271],"three":[279],"experiments":[281],"resulted":[282],"impaired":[284],"differentiation.":[286,454,540],"demonstrated":[289,348],"CD34,":[291],"CD117,":[292],"decreased":[294,314,493],"CD11b":[295,494],"culture":[298],"over":[299],"time.":[300],"ability":[302],"progenitors":[304,372,572],"form":[306],"CFU-GM":[307,352],"CFU-G":[309,350],"colonies":[310],"also":[312,322,431,528],"expressing":[317,326,370,484],"cells.":[318,592,654],"Myeloid":[319],"differentiation":[320,415,501,575,603,615],"inhibited":[323,573],"exposed":[328],"ATRA.":[330,361,482],"Correspondingly,":[331],"when":[332,585],"cells,":[340,486,491],"proliferation":[341,651],"formation":[353],"both":[354],"absence":[359],"Microarray":[362],"data":[363,618],"comparing":[364],"gene":[365],"profiles":[367],"control":[374,490],"suggested":[376],"EZH2":[378,387],"mediate":[380],"effects.":[382],"polycomb":[384],"group":[385],"protein":[386],"mediating":[392],"repressive":[394],"effects":[395,412],"RARA":[399,521],"ATRA":[405,497],"solid":[407],"ATRA,":[420],"however,":[421,595],"are":[422,647],"type":[424],"context":[426],"dependent.":[427],"examined":[432],"AML":[436,464],"highly":[441],"line":[447,466,473,514],"K562,":[448],"which":[449,515],"capable":[451],"erythroid":[453],"much":[459],"lower":[460],"HL60.":[467],"Cells":[468],"HL60":[471,485,525],"can":[474],"differentiated":[476],"into":[477],"neutrophils":[478],"after":[479,496],"exposure":[480],"exhibited":[492],"exposure.":[498],"comparison,":[500],"K562":[503,512],"not":[506],"affected":[507],"by":[508],"silencing.":[510],"A":[511],"expresses":[516],"receptors":[522],"(equal":[523],"cells)":[526],"examined,":[529],"silencing":[532],"these":[534,653],"had":[536],"effect":[538],"conclusion,":[542],"primarily":[546],"its":[552],"diagnosis":[555],"disease":[558],"associated":[560],"treatment":[563],"promyelocyte/myelocyte":[578],"level,":[579],"this":[581],"phenotype":[582],"reversed":[584],"progenitor":[591],"function,":[594],"dependent":[597,608],"lineage":[599],"commitment.":[600],"blocks":[602],"manner":[609],"potential.":[616],"These":[617],"suggest":[619],"increasing":[621],"progress":[626],"plays":[632],"role":[634],"inhibiting":[636],"differentiation,":[638],"other":[641],"genetic":[642],"events,":[643],"such":[644],"BCR-ABL,":[646],"needed":[648],"drive":[650]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2017-03-16T00:00:00"}